Latest news with #NAI
Yahoo
10 hours ago
- Business
- Yahoo
Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company
CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ('NAI') (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced it has extended its partnership with The Juice Plus+ Company ('Juice Plus+'), a globally recognized leader in plant-based whole-body nutritional products, through the execution of a new multi-year Manufacturing Agreement covering Juice Plus+ capsule and powder products sold in over 24 markets around the world. Mark A. LeDoux, NAI's CEO and Chairman of the Board, said, 'Continuing our 30+ year relationship with JuicePlus+ reflects our shared commitment to delivering premium nutritional products backed by extensive scientific research. Together, we remain focused on enhancing the health-promoting properties of the JuicePlus+ family of products.' Travis Garza, Juice Plus+ CEO, said, 'We are very pleased with our commercial relationship with NAI. Their commitment to quality and our global innovation plans has been impressive and consistent, and this contract extension recognizes the value of continuing these mutual efforts, and we are confident this extension will be mutually beneficial.' NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI's comprehensive partnership approach offers a wide range of innovative nutritional products and services to NAI's clients including: scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see its website at This press release contains forward-looking statements within the meaning of applicable securities laws that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, our expectations and beliefs with respect to the impact of this Agreement on our business. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI's financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q. CONTACT – Michael Fortin, Chief Financial Officer, Natural Alternatives International, Inc., at 760-736-7700 or investor@ Web site: SOURCE Natural Alternatives International, in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
News18
08-07-2025
- Politics
- News18
'Fragile, Rare, Priceless': Modi Govt To Digitise India's Manuscript Heritage
In the next three years, the Narendra Modi-led government will digitise thousands of ancient Indian manuscripts. According to a government tender from National Archives of India (NAI), many of the manuscripts are 'fragile, rare, deteriorating, brittle and to be handled with great care". For the digitisation project, a sum of Rs 50 crore has already been approved. These priceless records – some written on palm leaf, birch bark, parchment, cloth, or handmade paper – span a vast linguistic spectrum, including Sanskrit, Bengali, Malayalam, Tamil, Telugu, Arabic, and Persian, as per the document accessed by News 18. Hailed as India's most ambitious civilisational archiving mission to date, the groundwork for this digital effort was laid much earlier. The culture ministry initiated the process with at least three other websites – Indian Cultures, Abhilekh Patal, and the Indian Mission for Manuscripts. For years, various government and affiliated institutions quietly collected and preserved neglected manuscripts from temple libraries, scholar households, and oral traditions. In Maharashtra, Odisha, Tamil Nadu, and Kashi, teams collaborated with traditional scholars and researchers to digitise and catalogue regional scriptural records long before it became a priority. Now, the Centre is formalising this mission. According to the official document, the digitisation project will involve several procedures including unbinding, flattening, cleaning, scanning, quality control, metadata creation, optical character recognition (OCR) for applicable languages, and long-term digital storage. Once fully digitised, the content will be integrated into existing national knowledge systems through platforms such as the National Manuscripts Repository (NAMAMI), the National Virtual Library of India (NVLI), the Digital Library of India, the Bharatavani multilingual platform, and the government's flagship portal. These platforms will allow the general public to access and read the documents. This project is aimed at digitally preserving India's ancient manuscripts and important documents. The tender also mentions that several manuscripts are in 'an extremely fragile condition, susceptible to damage due to age and lack of proper storage", and stressed on the need for non-invasive digitisation using high-resolution scanners that do not expose records to heat or harsh lighting. Experts involved in the project told News18 that this effort is more than just preservation; it is a cultural reclamation.
Business Upturn
02-06-2025
- Business
- Business Upturn
Piramal Pharma successfully clears US FDA GMP inspection at Aurora facility
By Aman Shukla Published on June 2, 2025, 10:32 IST Piramal Pharma Limited has successfully completed the US FDA Good Manufacturing Practices (GMP) inspection at its Aurora, Canada facility. The inspection took place from May 26 to May 30, 2025. The US FDA conducted a thorough general GMP inspection, evaluating the facility's compliance with stringent manufacturing standards. Piramal Pharma's Aurora site was awarded a clean slate with zero Form 483 observations and received a No Action Indicated (NAI) designation, underscoring its commitment to excellence and regulatory compliance. This successful inspection reinforces Piramal Pharma's position as a leading pharmaceutical company dedicated to maintaining the highest quality standards in drug manufacturing. The company continuously strives to ensure the safety, efficacy, and quality of its products for patients worldwide. This successful inspection reinforces Piramal Pharma's position as a leading pharmaceutical company dedicated to maintaining the highest quality standards in drug manufacturing. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Insider
27-05-2025
- Business
- Business Insider
The Last Great (Non-Government) Paramount (NASDAQ:PARA) / Skydance Roadblock: Mario Gabelli
For everyone who has been keeping score at home, you know like I do that the merger between entertainment giant Paramount (PARA) and Skydance is far from a done deal. While Paramount still, at last report, believes that the merger can be completed before June ends, there were still some issues left. The Federal Communications Commission (FCC) has not yet signed off. A lawsuit between Paramount and President Donald Trump is still in place. Two smaller lawsuits from Rhode Island and New York City pension funds are in the way. Confident Investing Starts Here: And then, there is Mario Gabelli. Gabelli represents investors who, together, own around 12.5% of Paramount's class A voting shares. This makes Gabelli head of the second-largest bloc of class A shareholders next to Shari Redstone. And Gabelli has been objecting to the merger almost since its inception, but not much has been heard on that front recently. With that massive question mark in place, I went looking. I managed to find the contact information for Mr. Christopher Marangi, the co-CIO for GAMCO Investors, founded by Mario Gabelli himself. And over the course of several weeks, I managed to get Mr. Marangi to sit down for a few questions about the current state of the lawsuit, and just what was going on in relation to Mr. Gabelli's pursuit of Paramount. The Question and Answer Portion TipRanks: Back in July 2024, Mr. Gabelli brought in the lawsuit in Delaware's Chancery Court, seeking information to ensure investors got a worthwhile deal themselves. Paramount seemed concerned about that deal, to the point that reports noted that RedBird Capital's Gerry Cardinale was dispatched to speak to Mr. Gabelli personally about the matter. What was Mr. Gabelli hoping to find as a result of that case? Marangi: As you are aware, National Amusements chose to conduct the sale of Paramount through a two-step process. In Step 1, NAI would sell themselves (along with the controlling interest in Paramount) to Skydance and in Step 2, Skydance would merge with Paramount. As a practical matter, this had the effect of allowing Skydance/NAI to keep the price paid for NAI's Paramount stake confidential. In addition, the transaction was conducted without a shareholder vote which left GAMCO in the position of being forced to either take inferior stock (i.e. non-voting) in the merged company or cash that may have been deeply discounted from what NAI received. GAMCO launched what it has called Project Fishbowl to gather information about the deal struck between National Amusements (NAI) and Skydance/RedBird, including the price NAI had secured for its voting A shares. Delaware has a mechanism under Section 220 of Delaware Corporate Law that allows shareholders like GAMCO to review books and records of the Corporation including related to these negotiations. The matter eventually went before the Chancery because GAMCO was dissatisfied with the materials they were provided under Section 220. The Delaware Chancery Court issued a ruling regarding our 220 investigation saying that Gabelli 'has stated and proved a credible basis to suspect wrongdoing' by Paramount in its books and records action. TipRanks: As for the conversation between Mr. Gabelli and Gerry Cardinale, what topics did it cover? What actually came out of that conversation, if anything? Marangi: No comment. TipRanks: After that, in October 2024, reports from the New York Post noted that Mr. Gabelli was still taking meetings with lawyers in a bid to land 'a big payday for his clients.' But Mr. Gabelli also, the report noted, discovered that the lawyers in question were working for Paramount on one level or another. Has Mr. Gabelli managed to find a legal force that was sufficiently inclined to pursue Paramount, or is this still ongoing? Marangi: GAMCO, on behalf of our clients, had retained highly skilled counsel that has extensive experience in dealing with similar matters. TipRanks: In January 2025, a report from Bloomberg noted that Mr. Gabelli was looking for a set of files from Paramount, which were said to contain information on Shari Redstone's deal with Paramount / Skydance, and what she would specifically gain. Mr. Gabelli turned to a judge in said matter, as Paramount refused to hand over the files. A Quartz report from September 2024 revealed that Shari Redstone stood to make $530 million personally from the deal; has Mr. Gabelli's investigation found out anything contrary to that, or is that number accurate as it stands? Marangi: See response to question 1. The price NAI received for its voting A shares remains undisclosed though based on publicly available data we continue to suspect it was in excess of the $23 per share non-NAI shareholders are being offered for their A stock. TipRanks: After January 2025, information about Mr. Gabelli's pursuit of Paramount seems to have gone quiet. Where does his search stand today? Is there any hope of him preventing the Paramount / Skydance merger? Has he decided to abandon the pursuit altogether? Marangi: The merger remains subject to regulatory review. The 220 matter was before the Delaware Court in April. GAMCO has also notified the FCC regarding its objection to the merger without additional disclosure. It is unlikely GAMCO, or any shareholder for that matter, would be able to prevent the merger. GAMCO will continue to evaluate its options to protect the interests of the more than 700 of its clients who own Paramount stock. Overall? Not Much. And that is where we stand today. Though the answers were, perhaps, not as definitive as we would have hoped: further planned legal action or an attempt to derail the merger—even Mr. Marangi acknowledges the unlikeliness of preventing the Paramount / Skydance merger—all seem comparatively impossible to reach. But one thing is clear: at least now we know what the current state of affairs is. We also have a pretty good idea that any hope Paramount had of finishing the merger by July 4 is largely misplaced. There are simply too many outstanding issues as yet for this to conclude in the next two to six weeks. Is Paramount Stock a Good Buy Right Now? Turning to Wall Street, analysts have a Moderate Sell consensus rating on PARA stock based on two Buys, seven Holds and six Sells assigned in the past three months, as indicated by the graphic below. After a 0.33% loss in its share price over the past year, the average PARA price target of $11.92 per share implies 0.42% downside risk.
Yahoo
12-05-2025
- Science
- Yahoo
BYU leads in student inventor patents, recent study shows
PROVO, Utah () — Brigham Young University was recently ranked as one of the Top 100 universities in the U.S. for most-issued patents. What makes its ranking unique isn't just the number, but who holds the patents. The ranking, by the National Academy of Inventors, finds that of BYU's 18 newly-issued patents, 10 of them list students as inventors or co-inventors. Baby fox rescued after falling into irrigation drain in Farmington According to a BYU press release, published research shows that nationally only a small fraction of graduate students appear on a patent. For STEM Ph.D students, it's roughly 4%, including at R1 universities, or universities with a high level of research. BYU Technology Transfer Director Dave Brown said the BYU ranking is 'very unusual…in a good way.' 'When more than half of our U.S. patents list a student alongside a professor, that's campus … turning into a launchpad for invention,' Brown said. 'BYU is building inventors who can serve the world by solving real-life challenges.' As those patents are mixed with a large volume of faculty-only filings, the amount that is shared with a student inventor is usually in the 10-20% range, according to the AUTM licensing survey data and peer-reviewed studies. In comparison, BYU's share of patents with student inventors is 56%. 'BYU is in a very select group — fewer than a dozen U.S. institutions — where student inventors appear on a majority of issued patents,' Brown said. 'Making the NAI Top 100 ranking shows that BYU is succeeding at training the next generation.' Among the new patents that BYU students hold are: artificial vertebral endplates, electromagnetic trap multiplexing, integrated cleaning devices for optical instruments, and multi-stage stent devices. Among the BYU student co-inventors in the 2024 report, some of them are listed on multiple patents. The NAI Top 100 U.S. Universities is released annually and ranks U.S. academic institutions that play a role in the advancement of innovation through patents. The NAI has published the top 100 worldwide university list since 2013, adding the top 100 U.S. universities list in 2023. The University of California system tops the 2024 lists, with MIT, the University of Texas system, Purdue, and Stanford in the top 5. Local universities that made the rankings include the University of Utah, BYU, and Utah State University in that order. House Natural Resources Committee in Cedar City to discuss federal lands sales, geothermal energy President Trump announces plan to cut prescription drug costs House GOP unveils plan to raise debt limit by $4 trillion BYU leads in student inventor patents, recent study shows President Trump defends plan to accept Qatari luxury jet Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
